| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Gene |
| Molecule Category: | UNKNOWN |
| UNII: | 4MD2J2T8SJ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | B-lymphocyte antigen CD19 binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | D054198 | ClinicalTrials |
| Hematologic Neoplasms | 2 | D019337 | ClinicalTrials |
| Leukemia, Lymphoid | 2 | D007945 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | D015451 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594618 |
| FDA SRS | 4MD2J2T8SJ |
CONTENTS